FIGO Stage III Ovarian Cancer
2 clinical trials · Condition
◉ Watch FIGO Stage III Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (NCT05406674) | The Netherlands Cancer Institute | 2022-06-15 |
| First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT01097746) | M.D. Anderson Cancer Center | 2010-04-14 |
Track FIGO Stage III Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.